Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of CUE-101 in Combination With Pembrolizumab in Subjects With Newly Diagnosed, Locally Advanced HPV-16 Associated Head and Neck Cancer

NCT07172256 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT07172256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07172256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of CUE-101 in Combination With Pembrolizumab in Subjects With Newly Diagnosed, Locally Advanced HPV-16 Associated Head and Neck Cancer
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Recruiting
Start date
May 7, 2026
Completion date
February 28, 2031
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma, hpv positive oropharyngeal squamous cell carcinoma, locally advanced, new diagnosis tumor